SCHEMBL20642000

SCHEMBL20642000

Nc1nc(N2CCOCC2)ccc1NC(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.55
GAA P10253 4/20 0.55
MAPT P10636 2/20 0.55
MEN1 O00255 1/20 0.55
KMT2A Q03164 1/20 0.55
ALDH1A1 P00352 3/20 0.54
CCNT1 O60563 1/20 0.47
CDK4 P11802 1/20 0.47
CCND1 P24385 1/20 0.47
CDK9 P50750 1/20 0.47
CDK6 Q00534 1/20 0.47
CDK11A Q9UQ88 1/20 0.47
ATR Q13535 1/20 0.47
PTPN11 Q06124 1/20 0.45
CYP1A2 P05177 2/20 0.43
CYP2C19 P33261 1/20 0.43
HIF1A Q16665 1/20 0.43
PIK3CA P42336 1/20 0.43
IRAK4 Q9NWZ3 1/20 0.42
CRHBP P24387 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20654767 0.83 KDM4E (0.50) KDM4EGAAMAPTMEN1KMT2A
SCHEMBL4658361 0.79 KDM4E (0.49) KDM4EGAAMAPTMEN1KMT2A
SCHEMBL30590396 0.75 PRKDC (0.50) KDM4EGAAMAPTMEN1KMT2A
SCHEMBL31570599 0.75 SMPD3 (0.53) KDM4EGAAMAPTMEN1KMT2A
SCHEMBL939415 0.75 SMPD3 (0.53) KDM4EGAAMAPTMEN1KMT2A
SCHEMBL4658238 0.73 KDM4E (0.47) KDM4EGAAMAPTMEN1KMT2A
SCHEMBL4326786 0.73 ALDH1A1 (0.70) MEN1KMT2AALDH1A1CYP1A2CYP2C19
SCHEMBL21379546 0.72 MAPT (0.70) GAAMAPTMEN1KMT2AALDH1A1
SCHEMBL2260066 0.72 GAA (0.49) KDM4EGAAMAPTMEN1KMT2A
SCHEMBL24195931 0.72 SMPD3 (0.47) KDM4EGAAMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019014547-A1 FUNCTIONALIZED PYRIDINE CARBAMATES WITH ENHANCED NEUROPROTECTIVE ACTIVITY TEXAS TECH UNIVERSITY SYSTEM (US) 2019-01-17 WO disclosed